期刊文献+

Dll4基因靶向RNAi重组腺相关病毒载体的构建和高滴度病毒制备 被引量:2

Construction of recombined adeno-associated virus vector expressing Dll4 short RNA interference and preparation of high-titer virus
下载PDF
导出
摘要 目的:构建一个表达肿瘤血管生成调节基因Delta-like ligand4(Dll4)小干扰RNA的重组腺相关病毒载体,制备靶向性抑制Dll4表达的高滴度重组腺相关病毒。方法:将包含肿瘤血管生成调节基因Dll4特异性小干扰RNA片段的质粒用EcoRI+SalI双酶切,回收目的片段,将pSNAV2.0质粒用EcoRI+SalI双酶切后同目的片段连接,脂质体法转染BHK-2l细胞,G418筛选后以辅助病毒感染获取病毒。结果:PCR和测序证实,成功构建包含U6启动子和肿瘤血管生成调节基因Dll4特异性RNA干扰片段的重组腺相关病毒载体,并制备出滴度为2.4×l011vectorgenome/L高滴度腺相关病毒。结论:成功构建携带Dll4基因短发夹状干扰RNA的腺相关病毒载体。为下一步探索抗肿瘤血管生成基因治疗的新途径提供实验基础。 Objective: To construct the recombinant adeno-associated virus vector expressing tumor angiogenesis-related gene Dll4 short RNA interference(RNAi) and to use it for the preparation of high-titer virus. Methods: pDC316-Dll4-shRNA plasmid, constructed with Dll4 siRNA, was digested with EcoRI and SaIL A 1 500bp fragment, containing U6 promoter and Dll4 siRNA, was obtained and inserted into the adeno-associated virus vector plasmid pSNAV2.0 digested with EeoRI +SalI. Positive vectors were analyzed through enzyme digestion and DNA sequencing. The recombinant plasmid was transfected into BHK-21 cells using LipofectamineTM^2000. G418-resistant cells were obtained and infected with HSVI-rc/△UL2, which have the function of packaging recombinant adeno-associated virus (rAAV). After purification, target vector and virus were collected. Results: The target vector, pSNAV2.0-shRNA-Dll4, was successfully constructed, and the rAAV with a titer of 2.4 × 10^11 vg/L ( vg : vectorgenome) was obtained. Conclusion: rAAV vector may be used in further investigation of Dll4 function in tumor angiogenesis and gene therapy.
出处 《军医进修学院学报》 CAS 2009年第3期354-356,共3页 Academic Journal of Pla Postgraduate Medical School
基金 国家自然科学基金资助项目(30872468)~~
关键词 Delta-likeligand4(Dll4) RNA干扰 重组腺相关病毒 delta-like ligand 4 (Dll4) RNA interference recombinant adeno-associated virus (rAAV)
  • 相关文献

参考文献7

  • 1J.萨姆布鲁克.E.R弗里奇.分子克隆实验指南[M].北京:科学出版社.1992.
  • 2Synder RO,Xiao X,Samulski RJ.Production of recombinant adeno-associated viral vectors.In:Dracopoli N (ed).Current Protocols in Human Genetics.John Wiley:New York,1996,67(10):1211-1212.
  • 3Ellis LM,Hicklin DJ.Pathways mediating resistance to vascular endothelial growth factor-targeted therapy[J].Clin Cancer Res,2008,14(20):6371-6375.
  • 4Ridgway J,Zhang G,Wu Y,et al.Inhibition of DⅡ4 signalling inhibits tumour growth by deregulating angiogenesis[J].Nature,2006,444(7122):1083-1087.
  • 5Dufraine J,Funahashi Y,Kitajewski J.Notch signaling regulates tumor angiogenesis by diverse mechanisms[J].Oncegene,2008,27(38):5132-5137.
  • 6Flotte TR.Gene therapy progress and prospects:recombinant adeno-associated virus (rAAV) vectors[J].Gene Ther,2004,11(10):805-810
  • 7Brummelkamp TR,Bernards R,Agami R.A system for stable expression of short interfering RNAs in mammalian cells[J].Science,2002,296(5567):550-553.

共引文献9

同被引文献35

  • 1亢庆铮,曾淑兰,杨会勇,许瑞安.重组腺相关病毒介导的肿瘤基因治疗[J].中华临床医师杂志(电子版),2011,5(15):4489-4492. 被引量:1
  • 2Luo J, Luo Y, Sun J, et al. Adeno-associated virus-mediated cancer gene therapy : current status [ J ]. Cancer Lett, 2015, 356 ( 2 Pt B ): 347-356.
  • 3Lerch TF, O' donnell JK, Meyer NL, et al. Structure of AAV-DJ, a retargeted gene therapy vector : cryo-electron microscopy at 4.5 Aresolution [J]. Structure, 2012, 20 ( 8 ) : 1310-1320.
  • 4Su CH, Wu YJ, Wang HH, et al. Nonviral gene therapy largeIing cardiovascular system [ J ] . Am J Physiol Heart Cire Physiol, 2012, 303 ( 6 ) : H629-H638.
  • 5Petrs-Silva H, Linden R. Advances in recombinant adeno-assoeiated viral vectors for gene delivery[J]. Curr Gene Ther, 2013, 13 ( 5 ): 335-345.
  • 6Ylae-Herttuala S. Endgame : glybera finally recommended for approval as the first gene therapy drug in the European anion [J]. Mol Ther, 2012, 20 (10) : 1831-1832.
  • 7Zhang J, Kale V, Chen M. Gene-direeted enzyme prodmg therapy[J].AAPSJ. 2015, 17 ( 1 ) : 102-110.
  • 8Pan JG, Zhou X, Luo R, el al. The adeno-assoeiated virus-medialed HSV-TK/GCV suicide system : a potential strategy fi)r the treatment of bladder eareinoma [J] . Ned Oneol, 2012, 29 ( 3 ) : 1938-1947.
  • 9Kim JY, Kim JH, Khim M, et al. Persistent anli-tumor effe(qs via recombinant adeno-associated virus encoding herpes thymidine kinase gene monitored by PET-imaging [J].Oncol Rep, 2011, 25 ( 5 ) : 1263-1269.
  • 10Eu L, Luo ST, Shi HS, el al. AAV2-medialed gene lransfir of VEGF-Trap with potent suppression of primary breast lumor growth and spontaneous pulmonary metastases by long-term expression [J]. Oneol Rep, 2012, 28 (4): 1332-1338.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部